NCT05115422

Brief Summary

Cancer-related cognitive problems, also known as "brain fog", have a significant impact on patients with cancer and cancer survivors. Previous studies indicate that cancer and cancer treatments can negatively affect memory, attention and thinking abilities. Adolescents and young adults (AYAs) are individuals with a cancer diagnosis, who are currently between 18 to 40 years old. These individuals are especially vulnerable to brain fog symptoms due to the effect these symptoms have on their education, employment, health behaviors, mental health, and social relationships. There is a clear need for programming directed at brain fog symptoms among AYAs with cancer diagnoses. The 'Coping with Brain Fog' program, developed by Maximum Capacity Inc., is an eight-week group program that has been designed to educate patients about their brain fog symptoms and develop strategies to manage these symptoms. In this study the investigators will aim to determine the feasibility of adapting the 'Coping with Brain Fog' program to the virtual setting for AYAs with cancer during the COVID-19 pandemic. The investigators will also aim to explore the efficacy of the program on cognitive functioning and symptoms of anxiety, depression and fatigue. This study is an important step towards finding ways to treat brain fog symptoms in cancer patients, and could help guide future studies and programs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

5 months

First QC Date

October 16, 2021

Last Update Submit

May 20, 2022

Conditions

Keywords

Brain fogPsychological DistressAnxietyDepressionFatigue

Outcome Measures

Primary Outcomes (2)

  • Adherence

    The investigators will measure the adherence to the intervention by measuring attendance at the weekly sessions. The intervention will be considered feasible if 60% of participants do not miss the first two sessions and any two consecutive sessions.

    Adherence will be assessed at the end of the 8-week intervention.

  • Participant Satisfaction - Client Satisfaction Questionnaire

    The participants' satisfaction with the program will be measured using The Client Satisfaction Questionnaire (CSQ), an 8-item self-report scale which will be administered at the end of the intervention to assess the participant satisfaction. Each item on this scale is scored from 1 to 4, generating a total score ranging from 8 to 32. A total score of 8-20 indicates low satisfaction, whereas total scores of 21-26 and 27-32 indicate medium and higher satisfaction, respectively.

    Participant Satisfaction will be measured at the end of the 8-week intervention.

Secondary Outcomes (6)

  • Perceived Cognitive Functioning - Functional Assessment of Cancer Therapy-Cognitive Function Scale

    The investigators will measure perceived cognitive functioning before, one week after, and 6-8 weeks after the intervention.

  • Perceived Cognitive Functioning - Cancer Distress Scales for Adolescents and Young Adults

    The investigators will measure perceived cognitive functioning before, one week after, and 6-8 weeks after the intervention.

  • Symptoms of Distress and Fatigue - Anxiety

    The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.

  • Symptoms of Distress and Fatigue - Depression

    The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.

  • Symptoms of Distress and Fatigue - Fatigue

    The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.

  • +1 more secondary outcomes

Study Arms (1)

"Coping with Brain Fog" intervention

EXPERIMENTAL
Behavioral: 'Coping with Brain Fog' program

Interventions

The proposed intervention is an 8-week 'Coping with Brain Fog' program for cancer survivors, adapted for AYAs with cancer, with one 90-minute group session per week. The intended group size for the program is 8-12 participants. The program was developed to be delivered in person, however for the purposes of this study it will be conducted in a virtual setting. The overall goals of the program are to educate participants about cancer-related brain fog and enhance their cognitive function and wellbeing. To accomplish this, the program is segmented into three main components: memory skills, task management, and psychological wellbeing. For each component, participants are systematically introduced to evidence-based strategies to cumulatively build a repertoire of cognitive tools designed to reduce the impact of cancer-related brain fog. The program uses a manual and participant materials that are copyrighted by Maximum Capacity Inc.

"Coping with Brain Fog" intervention

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-40 years
  • Diagnosed with any type or stage of cancer
  • Seeking intervention for self-reported symptoms of brain fog (such as poor memory, mental slowness, or task insufficiency)
  • Must be currently living in Manitoba, Nunavut or Northwest Ontario
  • Must be able to attend eight virtual sessions of the 'Coping with Brain Fog' intervention
  • Must have reliable access to the internet and the audio-visual platform Zoom
  • Should also be able to read, speak and write English (as the sessions will be conducted in English)

You may not qualify if:

  • Age younger than 18 or older than 40 years at the time of enrollment
  • Must not have a previously diagnosed severe intellectual disability (self-reported by the participants)
  • Should not be receiving any new interventions to enhance their cognitive function during the period of this study
  • Must attend the first two sessions and should not miss two consecutive sessions (if a participant misses two consecutive sessions due to extenuating circumstances, they will be encouraged to withdraw from the group and be prioritized on the wait-list for the next brain fog group)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CancerCare Manitoba

Winnipeg, Manitoba, R3E 0V9, Canada

Location

Related Publications (12)

  • Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive Changes in Cancer Survivors. Am Soc Clin Oncol Educ Book. 2018 May 23;38:795-806. doi: 10.1200/EDBK_201179.

    PMID: 30231372BACKGROUND
  • Jean-Pierre P, Winters PC, Ahles TA, Antoni M, Armstrong FD, Penedo F, Lipshultz SE, Miller TL, Fiscella K. Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract. 2012 Jan;8(1):30-4. doi: 10.1200/JOP.2011.000231. Epub 2011 Nov 22.

    PMID: 22548008BACKGROUND
  • Prasad PK, Hardy KK, Zhang N, Edelstein K, Srivastava D, Zeltzer L, Stovall M, Seibel NL, Leisenring W, Armstrong GT, Robison LL, Krull K. Psychosocial and Neurocognitive Outcomes in Adult Survivors of Adolescent and Early Young Adult Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Aug 10;33(23):2545-52. doi: 10.1200/JCO.2014.57.7528. Epub 2015 Jul 6.

    PMID: 26150441BACKGROUND
  • McDougall GJ Jr, Oliver JS, Scogin F. Memory and cancer: a review of the literature. Arch Psychiatr Nurs. 2014 Jun;28(3):180-6. doi: 10.1016/j.apnu.2013.12.005. Epub 2014 Mar 22.

    PMID: 24856270BACKGROUND
  • Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol. 2012 Oct 20;30(30):3675-86. doi: 10.1200/JCO.2012.43.0116. Epub 2012 Sep 24.

    PMID: 23008308BACKGROUND
  • Barnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L, Touza K, Jhanwar S, Atkinson TM, Ford JS. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016 Oct;10(5):814-31. doi: 10.1007/s11764-016-0527-6. Epub 2016 Feb 26.

    PMID: 26920873BACKGROUND
  • Perales MA, Drake EK, Pemmaraju N, Wood WA. Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Curr Hematol Malig Rep. 2016 Dec;11(6):449-455. doi: 10.1007/s11899-016-0313-6.

    PMID: 26893061BACKGROUND
  • Anderson C, Nichols HB. Trends in Late Mortality Among Adolescent and Young Adult Cancer Survivors. J Natl Cancer Inst. 2020 Oct 1;112(10):994-1002. doi: 10.1093/jnci/djaa014.

    PMID: 32123906BACKGROUND
  • Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020 Nov;70(6):443-459. doi: 10.3322/caac.21637. Epub 2020 Sep 17.

    PMID: 32940362BACKGROUND
  • Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available.

    PMID: 10245370BACKGROUND
  • Tsangaris E, D'Agostino N, Rae C, Breakey V, Klassen AF. Development and Psychometric Evaluation of the Cancer Distress Scales for Adolescent and Young Adults. J Adolesc Young Adult Oncol. 2019 Oct;8(5):566-580. doi: 10.1089/jayao.2019.0005. Epub 2019 Jul 8.

    PMID: 31274372BACKGROUND
  • Muthumuni D, Scott I, Chochinov HM, Mahar AL, Garland SN, Schulte F, Lambert P, Lix L, Garland A, Oberoi S. Feasibility and Acceptability of a Virtual "Coping with Brain Fog" Intervention for Improving Cognitive Functioning in Young Adults with Cancer. J Adolesc Young Adult Oncol. 2023 Oct;12(5):662-673. doi: 10.1089/jayao.2023.0022. Epub 2023 May 8.

Related Links

MeSH Terms

Conditions

NeoplasmsCognitive DysfunctionMental FatigueAnxiety DisordersDepressionFatigue

Interventions

Coping Skills

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pilot study of the virtual 'Coping with Brain Fog' intervention for AYAs with cancer living in Manitoba.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Hematologist Oncologist

Study Record Dates

First Submitted

October 16, 2021

First Posted

November 10, 2021

Study Start

November 1, 2021

Primary Completion

March 31, 2022

Study Completion

October 31, 2022

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations